Protective Effect of Korean Red Ginseng Extract on Cisplatin Ototoxicity in HEI-OC1 Auditory Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Im, Gi Jung | - |
dc.contributor.author | Chang, Ji Won | - |
dc.contributor.author | Choi, June | - |
dc.contributor.author | Chae, Sung Won | - |
dc.contributor.author | Ko, Eun Ju | - |
dc.contributor.author | Jung, Hak Hyun | - |
dc.date.accessioned | 2021-09-08T04:12:34Z | - |
dc.date.available | 2021-09-08T04:12:34Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2010-04 | - |
dc.identifier.issn | 0951-418X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/116724 | - |
dc.description.abstract | Ginseng extract is known to have many beneficial effects, including the reversal of pathological and physiological changes induced by ischemia, stress, and aging. Cisplatin, an effective antineoplastic drug, can cause irreversible sensorineural hearing loss and serious tinnitus in humans; thus cisplatin-induced ototoxicity is a useful experimental model for ototoxicity. This study investigated the protective effects of Korean red ginseng extract on cisplatin-induced ototoxicity in auditory cells. Pretreatment with 2.5 mg/mL of ginseng extract prior to application of 20 mu M of cisplatin significantly increased cell viability after 48 h of incubation in auditory cells. Pretreatment with ginseng extract significantly attenuated the cisplatin-induced increase in reactive oxygen species (ROS). Ginseng extract also inhibited the expression of caspase-3 and poly-ADP-ribose polymerase related to cisplatin-induced apoptosis because a major mechanism of cisplatin-induced toxicity involves ROS production. Thus, Korean red ginseng extract can play both an anti-apoptotic and anti-oxidative role on cisplatin-induced ototoxicity in an auditory cell line. Copyright (C) 2009 John Wiley & Sons, Ltd. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | INDUCED APOPTOSIS | - |
dc.subject | RG1 | - |
dc.subject | RB1 | - |
dc.subject | GINSENOSIDES | - |
dc.subject | MECHANISM | - |
dc.subject | NEURONS | - |
dc.title | Protective Effect of Korean Red Ginseng Extract on Cisplatin Ototoxicity in HEI-OC1 Auditory Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Im, Gi Jung | - |
dc.contributor.affiliatedAuthor | Choi, June | - |
dc.contributor.affiliatedAuthor | Chae, Sung Won | - |
dc.contributor.affiliatedAuthor | Jung, Hak Hyun | - |
dc.identifier.doi | 10.1002/ptr.3082 | - |
dc.identifier.scopusid | 2-s2.0-77951554548 | - |
dc.identifier.wosid | 000276802500024 | - |
dc.identifier.bibliographicCitation | PHYTOTHERAPY RESEARCH, v.24, no.4, pp.614 - 621 | - |
dc.relation.isPartOf | PHYTOTHERAPY RESEARCH | - |
dc.citation.title | PHYTOTHERAPY RESEARCH | - |
dc.citation.volume | 24 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 614 | - |
dc.citation.endPage | 621 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | INDUCED APOPTOSIS | - |
dc.subject.keywordPlus | RG1 | - |
dc.subject.keywordPlus | RB1 | - |
dc.subject.keywordPlus | GINSENOSIDES | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordPlus | NEURONS | - |
dc.subject.keywordAuthor | ginseng | - |
dc.subject.keywordAuthor | cisplatin | - |
dc.subject.keywordAuthor | ototoxicity | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.